Immunology and Microbiology
Immunoglobulin E
100%
Immunoglobulin E Antibody
56%
Macrophage
44%
Chondroitin Sulfate Proteoglycan
36%
Immunotherapy
36%
Tumor Antigen
31%
Xenograft
24%
Melanoma Antigen
24%
Cancer Cell
21%
Immunocompetent Cell
20%
Monoclonal Antibody
19%
Basophil
16%
Fc Receptor
15%
Immune System
15%
Autoimmunity
15%
Therapeutic Antibodies
14%
Cancer Immunotherapy
14%
Rat Model
13%
Mediator
13%
Immune Tolerance
12%
B Cell
12%
Immunoglobulin G1
12%
Systemic-Onset Juvenile Idiopathic Arthritis
12%
CTLA-4
12%
Chimeric Antigen Receptor T-Cell
12%
Cell Growth
9%
Effector Cell
9%
Tumor Cell
8%
Tumor-Associated Macrophage
8%
RNAI
8%
Tumor Necrosis Factor
7%
Immune Response
6%
Overall Survival
6%
Cytotoxicity
6%
Programmed Death-Ligand 1
6%
Basophil Activation
6%
Preclinical Study
6%
Signal Transduction
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
47%
Folate Receptor 1
36%
Malignant Neoplasm
34%
Melanoma
24%
Immunoglobulin E
24%
Folic Acid Antagonist
24%
Ovary Cancer
18%
Immunoglobulin E Antibody
15%
Immune Checkpoint Inhibitor
12%
Cytotoxic T Lymphocyte Antigen 4
12%
Folate Receptor
12%
Phase I Trials
12%
Solid Malignant Neoplasm
12%
Triple Negative Breast Cancer
12%
Combination Therapy
9%
Tumor Necrosis Factor
6%
Casein Kinase
6%
Mitogen Activated Protein Kinase
6%
Medicine and Dentistry
Neoplasm
32%
Ovarian Cancer
25%
Melanoma
24%
Folate Receptor 1
24%
Cancer Therapy
13%
Immunosuppressive Drug
12%
Repolarization
12%
Cell Interaction
12%
Immunoglobulin E Antibody
12%
Macrophage
12%
Immune Checkpoint Inhibitor
12%
CTLA-4
12%
Triple Negative Breast Cancer
12%
Antifolate
12%
Antibody Therapy
12%
Immunoglobulin E
9%
Combination Therapy
9%
Immune Response
9%
Malignant Neoplasm
7%
Immune System
7%
Casein Kinase
6%
extracellular signal regulated kinase
6%
Programmed Death-Ligand 1
6%
Cancer Cell
5%
Cancer
5%
Krukenberg Tumor
5%